20/20 BioResponse in Baltimore

Baltimore, MD, May 29–30, 2015—The 2015 IAFC Hazmat Conference was held in Baltimore, affording 20/20 BioResponse the opportunity to see many customers face to face, making every moment count. The conference was also a chance to forge new relationships...

SAFETY Act Designation awarded to BioCheck product

The BioCheck® Powdered Screening Test Kit, a product of 20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. has earned designation as a Qualified Anti-Terrorism Technology under the U.S. Department of Homeland Security (DHS)’s SAFETY Act . The...

Second Patent Issued to 20/20 for its BioCheck technology

Contact: Jonathan Cohen 20/20 GeneSystems, Inc. Tel. 240-453-6339 Jcohen@2020gene.com ROCKVILLE, MARYLAND – December 29, 2005 – 20/20 GeneSystems, Inc. (20/20) has been issued US Patent # 6,958,242, the second patent to cover the technology employed in...